Drug Shortage Report for TEVA-RIVAROXABAN
| Report ID | 227456 |
| Drug Identification Number | 02507226 |
| Brand name | TEVA-RIVAROXABAN |
| Common or Proper name | RIVAROXABAN 20MG FC TAB |
| Company Name | TEVA CANADA LIMITED |
| Market Status | MARKETED |
| Active Ingredient(s) | RIVAROXABAN |
| Strength(s) | 20MG |
| Dosage form(s) | TABLET |
| Route of administration | ORAL |
|
Packaging sizes (GTIN)
Click here to see a list of all reports for this drug. |
(See additional packaging sizes) |
| Additional packaging sizes | 100 |
| ATC code | B01AF |
| ATC description | ANTITHROMBOTIC AGENTS |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | |
| Actual start date | 2024-05-08 |
| Estimated end date | 2024-06-10 |
| Actual end date | 2024-06-14 |
| Shortage status | Resolved |
| Updated date | 2024-06-17 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 30 NOVOPHARM COURT TORONTO, ONTARIO CANADA M1B 2K9 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v6 | 2024-06-17 | French | Compare |
| v5 | 2024-06-17 | English | Compare |
| v4 | 2024-06-07 | French | Compare |
| v3 | 2024-06-07 | English | Compare |
| v2 | 2024-05-09 | French | Compare |
| v1 | 2024-05-09 | English | Compare |
Showing 1 to 6 of 6